牧島 秀樹

Last Update: 2019/06/28 18:05:05

Print

Name(Kanji/Kana/Abecedarium Latinum)
牧島 秀樹/マキシマ ヒデキ/Makishima, Hideki
Primary Affiliation(Org1/Job title)
Graduate Schools Medicine/Associate Professor
Faculty
Org1 Job title
医学部
E-mail Address
makishima.hideki.8x @ kyoto-u.ac.jp
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本血液学会
日本内科学会
日本癌学会
日本臨床腫瘍学会
日本造血細胞移植学会
Academic Organizations Overaseas You are Affiliated to
Organization name Country
American Society of Hematology USA
American College of Physicians USA
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 信州大学
Graduate School
University(Japanese) University(English) Faculty(Japanese) Faculty(English) Major(Japanese) Major(English) Degree
信州大学 大学院医学系研究科医学系専攻博士課程 修了
Undergraduate School / Major(s)
University(Japanese) University(English) Faculty(Japanese) Faculty(English) Major(s)(Japanese) Major(s)(English) Degree
名古屋大学 医学部医学科 卒業
ORCID ID
https://orcid.org/0000-0001-5983-8578
researchmap URL
https://researchmap.jp/read0132488
Research Topics
(Japanese)
悪性腫瘍におけるゲノム解析
(English)
Genetic study in hematological malignancy and solid tumor
Overview of the research
(Japanese)
血液悪性腫瘍、各種固形がんにおいてゲノム異常を解析し、下流のエピゲノム異常と遺伝子・蛋白発現を含めてそれら悪性腫瘍の原因を明らかにし、そのなかから病理学的・臨床的に重要な抽出することにより、治療ターゲット分子を発見し、新規治療を開発する。
(English)
As a physician-scientist, the focus of my interest is translational research directly targeting hematologic and solid cancer. My immediate goals are to systematically clarify the molecular mechanisms of myeloid neoplasms and other cancers and ultimately improve management of these conditions. As such, academic research is the best pathway to achieving these goals.
Fields of research (key words)
Key words(Japanese) Key words(English)
骨髄異形成症候群 Myelodyaplastic syndromes
急性骨髄性白血病 Acute myeloid leukemia
食道がん Esophageal cancer
大腸がん Colon cancer
ゲノム異常 Genetic lesions
固形がん Solid tumors
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi W, Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, Uaprasert N, Kongkiatkamon S, Moonla C, Sanada M, Akita N, Takeda J, Fujii Y, Suzuki H, Nannya Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Rojnuckarin P, Ogawa S, Makishima H Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi W, Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, Uaprasert N, Kongkiatkamon S, Moonla C, Sanada M, Akita N, Takeda J, Fujii Y, Suzuki H, Nannya Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Rojnuckarin P, Ogawa S, Makishima H Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi W, Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, Uaprasert N, Kongkiatkamon S, Moonla C, Sanada M, Akita N, Takeda J, Fujii Y, Suzuki H, Nannya Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Rojnuckarin P, Ogawa S, Makishima H Frequent germline mutations of <i>HAVCR2</i> in sporadic subcutaneous panniculitis-like T-cell lymphoma. Frequent germline mutations of <i>HAVCR2</i> in sporadic subcutaneous panniculitis-like T-cell lymphoma. Frequent germline mutations of <i>HAVCR2</i> in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood advances, 3, 4, 588-595 Blood advances, 3, 4, 588-595 Blood advances, 3, 4, 588-595 2019/02 Refereed Disclose to all
Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature, 565, 7739, 312-317 Nature, 565, 7739, 312-317 Nature, 565, 7739, 312-317 2019/01 Refereed Disclose to all
Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia Leukemia Leukemia 2019/01 Refereed Disclose to all
Nagata Y, Narumi S, Guan Y, Przychodzen BP, Hirsch CM, Makishima H, Shima H, Aly M, Pastor V, Kuzmanovic T, Radivoyevitch T, Adema V, Awada H, Yoshida K, Li S, Sole F, Hanna R, Jha BK, LaFramboise T, Ogawa S, Sekeres MA, Wlodarski MW, Cammenga J, Maciejewski JP Nagata Y, Narumi S, Guan Y, Przychodzen BP, Hirsch CM, Makishima H, Shima H, Aly M, Pastor V, Kuzmanovic T, Radivoyevitch T, Adema V, Awada H, Yoshida K, Li S, Sole F, Hanna R, Jha BK, LaFramboise T, Ogawa S, Sekeres MA, Wlodarski MW, Cammenga J, Maciejewski JP Nagata Y, Narumi S, Guan Y, Przychodzen BP, Hirsch CM, Makishima H, Shima H, Aly M, Pastor V, Kuzmanovic T, Radivoyevitch T, Adema V, Awada H, Yoshida K, Li S, Sole F, Hanna R, Jha BK, LaFramboise T, Ogawa S, Sekeres MA, Wlodarski MW, Cammenga J, Maciejewski JP Germline loss of function <i>SAMD9</i> and <i>SAMD9L</i> alterations in adult myelodysplastic syndromes. Germline loss of function <i>SAMD9</i> and <i>SAMD9L</i> alterations in adult myelodysplastic syndromes. Germline loss of function <i>SAMD9</i> and <i>SAMD9L</i> alterations in adult myelodysplastic syndromes. Blood, 132, 21, 2309-2313 Blood, 132, 21, 2309-2313 Blood, 132, 21, 2309-2313 2018/10 Refereed Disclose to all
Kotani S, Yoda A, Kon A, Kataoka K, Ochi Y, Shiozawa Y, Hirsch C, Takeda J, Ueno H, Yoshizato T, Yoshida K, Nakagawa MM, Nannya Y, Kakiuchi N, Yamauchi T, Aoki K, Shiraishi Y, Miyano S, Maeda T, Maciejewski JP, Takaori-Kondo A, Ogawa S, Makishima H Kotani S, Yoda A, Kon A, Kataoka K, Ochi Y, Shiozawa Y, Hirsch C, Takeda J, Ueno H, Yoshizato T, Yoshida K, Nakagawa MM, Nannya Y, Kakiuchi N, Yamauchi T, Aoki K, Shiraishi Y, Miyano S, Maeda T, Maciejewski JP, Takaori-Kondo A, Ogawa S, Makishima H Kotani S, Yoda A, Kon A, Kataoka K, Ochi Y, Shiozawa Y, Hirsch C, Takeda J, Ueno H, Yoshizato T, Yoshida K, Nakagawa MM, Nannya Y, Kakiuchi N, Yamauchi T, Aoki K, Shiraishi Y, Miyano S, Maeda T, Maciejewski JP, Takaori-Kondo A, Ogawa S, Makishima H Molecular pathogenesis of disease progression in MLL-rearranged AML. Molecular pathogenesis of disease progression in MLL-rearranged AML. Molecular pathogenesis of disease progression in MLL-rearranged AML. Leukemia, 33, 3, 612-624 Leukemia, 33, 3, 612-624 Leukemia, 33, 3, 612-624 2018/09 Refereed Disclose to all
Shiozawa Y, Malcovati L, Gallì A, Sato-Otsubo A, Kataoka K, Sato Y, Watatani Y, Suzuki H, Yoshizato T, Yoshida K, Sanada M, Makishima H, Shiraishi Y, Chiba K, Hellström-Lindberg E, Miyano S, Ogawa S, Cazzola M Shiozawa Y, Malcovati L, Gallì A, Sato-Otsubo A, Kataoka K, Sato Y, Watatani Y, Suzuki H, Yoshizato T, Yoshida K, Sanada M, Makishima H, Shiraishi Y, Chiba K, Hellström-Lindberg E, Miyano S, Ogawa S, Cazzola M Shiozawa Y, Malcovati L, Gallì A, Sato-Otsubo A, Kataoka K, Sato Y, Watatani Y, Suzuki H, Yoshizato T, Yoshida K, Sanada M, Makishima H, Shiraishi Y, Chiba K, Hellström-Lindberg E, Miyano S, Ogawa S, Cazzola M Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Nature communications, 9, 1, 3649 Nature communications, 9, 1, 3649 Nature communications, 9, 1, 3649 2018/09 Refereed Disclose to all
Katagiri S, Umezu T, Azuma K, Asano M, Akahane D, Makishima H, Yoshida K, Watatani Y, Chiba K, Miyano S, Ogawa S, Ohyashiki JH, Ohyashiki K Katagiri S, Umezu T, Azuma K, Asano M, Akahane D, Makishima H, Yoshida K, Watatani Y, Chiba K, Miyano S, Ogawa S, Ohyashiki JH, Ohyashiki K Katagiri S, Umezu T, Azuma K, Asano M, Akahane D, Makishima H, Yoshida K, Watatani Y, Chiba K, Miyano S, Ogawa S, Ohyashiki JH, Ohyashiki K Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia. Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia. Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia. Leukemia & lymphoma, 59, 6, 1490-1493 Leukemia & lymphoma, 59, 6, 1490-1493 Leukemia & lymphoma, 59, 6, 1490-1493 2018/06 Refereed Disclose to all
Clemente MJ, Przychodzen B, Hirsch CM, Nagata Y, Bat T, Wlodarski MW, Radivoyevitch T, Makishima H, Maciejewski JP Clemente MJ, Przychodzen B, Hirsch CM, Nagata Y, Bat T, Wlodarski MW, Radivoyevitch T, Makishima H, Maciejewski JP Clemente MJ, Przychodzen B, Hirsch CM, Nagata Y, Bat T, Wlodarski MW, Radivoyevitch T, Makishima H, Maciejewski JP Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria. Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria. Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria. Leukemia, 32, 11, 2507-2511 Leukemia, 32, 11, 2507-2511 Leukemia, 32, 11, 2507-2511 2018/04 Refereed Disclose to all
Molenaar RJ, Radivoyevitch T, Nagata Y, Khurshed M, Przychodzen B, Makishima H, Xu M, Bleeker FE, Wilmink JW, Carraway HE, Mukherjee S, Sekeres MA, van Noorden CJF, Maciejewski JP Molenaar RJ, Radivoyevitch T, Nagata Y, Khurshed M, Przychodzen B, Makishima H, Xu M, Bleeker FE, Wilmink JW, Carraway HE, Mukherjee S, Sekeres MA, van Noorden CJF, Maciejewski JP Molenaar RJ, Radivoyevitch T, Nagata Y, Khurshed M, Przychodzen B, Makishima H, Xu M, Bleeker FE, Wilmink JW, Carraway HE, Mukherjee S, Sekeres MA, van Noorden CJF, Maciejewski JP <i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors. <i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors. <i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research, 24, 7, 1705-1715 Clinical cancer research : an official journal of the American Association for Cancer Research, 24, 7, 1705-1715 Clinical cancer research : an official journal of the American Association for Cancer Research, 24, 7, 1705-1715 2018/04 Refereed Disclose to all
Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway HE, Sekeres MA, Radivoyevitch T, Yoshida K, Sanada M, Yoshizato T, Kataoka K, Nakagawa MM, Ueno H, Nannya Y, Kon A, Shiozawa Y, Takeda J, Shiraishi Y, Chiba K, Miyano S, Singh J, Padgett RA, Ogawa S, Maciejewski JP, Makishima H Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway HE, Sekeres MA, Radivoyevitch T, Yoshida K, Sanada M, Yoshizato T, Kataoka K, Nakagawa MM, Ueno H, Nannya Y, Kon A, Shiozawa Y, Takeda J, Shiraishi Y, Chiba K, Miyano S, Singh J, Padgett RA, Ogawa S, Maciejewski JP, Makishima H Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway HE, Sekeres MA, Radivoyevitch T, Yoshida K, Sanada M, Yoshizato T, Kataoka K, Nakagawa MM, Ueno H, Nannya Y, Kon A, Shiozawa Y, Takeda J, Shiraishi Y, Chiba K, Miyano S, Singh J, Padgett RA, Ogawa S, Maciejewski JP, Makishima H A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. Leukemia, 32, 3, 839-843 Leukemia, 32, 3, 839-843 Leukemia, 32, 3, 839-843 2018/03 Refereed Disclose to all
Przychodzen B, Makishima H, Sekeres MA, Balasubramanian SK, Thota S, Patel BJ, Clemente M, Hirsch C, Dienes B, Maciejewski JP Przychodzen B, Makishima H, Sekeres MA, Balasubramanian SK, Thota S, Patel BJ, Clemente M, Hirsch C, Dienes B, Maciejewski JP Przychodzen B, Makishima H, Sekeres MA, Balasubramanian SK, Thota S, Patel BJ, Clemente M, Hirsch C, Dienes B, Maciejewski JP Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML. Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML. Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML. Oncotarget, 9, 2, 2050-2057 Oncotarget, 9, 2, 2050-2057 Oncotarget, 9, 2, 2050-2057 2018/01 Refereed Disclose to all
Makishima H Makishima H Makishima H [Clonal hematopoiesis in aplastic anemia]. [Clonal hematopoiesis in aplastic anemia]. [Clonal hematopoiesis in aplastic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 10, 1962-1968 [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 10, 1962-1968 [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 10, 1962-1968 2018 Refereed Disclose to all
Shiozawa Y, Malcovati L, Gallì A, Pellagatti A, Karimi M, Sato-Otsubo A, Sato Y, Suzuki H, Yoshizato T, Yoshida K, Shiraishi Y, Chiba K, Makishima H, Boultwood J, Hellström-Lindberg E, Miyano S, Cazzola M, Ogawa S Shiozawa Y, Malcovati L, Gallì A, Pellagatti A, Karimi M, Sato-Otsubo A, Sato Y, Suzuki H, Yoshizato T, Yoshida K, Shiraishi Y, Chiba K, Makishima H, Boultwood J, Hellström-Lindberg E, Miyano S, Cazzola M, Ogawa S Shiozawa Y, Malcovati L, Gallì A, Pellagatti A, Karimi M, Sato-Otsubo A, Sato Y, Suzuki H, Yoshizato T, Yoshida K, Shiraishi Y, Chiba K, Makishima H, Boultwood J, Hellström-Lindberg E, Miyano S, Cazzola M, Ogawa S Gene expression and risk of leukemic transformation in myelodysplasia. Gene expression and risk of leukemic transformation in myelodysplasia. Gene expression and risk of leukemic transformation in myelodysplasia. Blood, 130, 24, 2642-2653 Blood, 130, 24, 2642-2653 Blood, 130, 24, 2642-2653 2017/12 Refereed Disclose to all
Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T, Clemente M, Hirsch C, Morawski A, Souaid R, Saygin C, Nazha A, Demarest B, LaFramboise T, Sakaguchi H, Kojima S, Carraway HE, Ogawa S, Makishima H, Sekeres MA, Maciejewski JP Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T, Clemente M, Hirsch C, Morawski A, Souaid R, Saygin C, Nazha A, Demarest B, LaFramboise T, Sakaguchi H, Kojima S, Carraway HE, Ogawa S, Makishima H, Sekeres MA, Maciejewski JP Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T, Clemente M, Hirsch C, Morawski A, Souaid R, Saygin C, Nazha A, Demarest B, LaFramboise T, Sakaguchi H, Kojima S, Carraway HE, Ogawa S, Makishima H, Sekeres MA, Maciejewski JP Genomic determinants of chronic myelomonocytic leukemia. Genomic determinants of chronic myelomonocytic leukemia. Genomic determinants of chronic myelomonocytic leukemia. Leukemia, 31, 12, 2815-2823 Leukemia, 31, 12, 2815-2823 Leukemia, 31, 12, 2815-2823 2017/12 Refereed Disclose to all
Negoro E, Nagata Y, Clemente MJ, Hosono N, Shen W, Nazha A, Yoshizato T, Hirsch C, Przychodzen B, Mahfouz RZ, Kuzmanovic T, Sekeres MA, Makishima H, Ogawa S, Maciejewski JP Negoro E, Nagata Y, Clemente MJ, Hosono N, Shen W, Nazha A, Yoshizato T, Hirsch C, Przychodzen B, Mahfouz RZ, Kuzmanovic T, Sekeres MA, Makishima H, Ogawa S, Maciejewski JP Negoro E, Nagata Y, Clemente MJ, Hosono N, Shen W, Nazha A, Yoshizato T, Hirsch C, Przychodzen B, Mahfouz RZ, Kuzmanovic T, Sekeres MA, Makishima H, Ogawa S, Maciejewski JP Origins of myelodysplastic syndromes after aplastic anemia. Origins of myelodysplastic syndromes after aplastic anemia. Origins of myelodysplastic syndromes after aplastic anemia. Blood, 130, 17, 1953-1957 Blood, 130, 17, 1953-1957 Blood, 130, 17, 1953-1957 2017/10 Refereed Disclose to all
Enane FO, Shuen WH, Gu X, Quteba E, Przychodzen B, Makishima H, Bodo J, Ng J, Chee CL, Ba R, Seng Koh L, Lim J, Cheong R, Teo M, Hu Z, Ng KP, Maciejewski J, Radivoyevitch T, Chung A, Ooi LL, Tan YM, Cheow PC, Chow P, Chan CY, Lim KH, Yerian L, Hsi E, Toh HC, Saunthararajah Y Enane FO, Shuen WH, Gu X, Quteba E, Przychodzen B, Makishima H, Bodo J, Ng J, Chee CL, Ba R, Seng Koh L, Lim J, Cheong R, Teo M, Hu Z, Ng KP, Maciejewski J, Radivoyevitch T, Chung A, Ooi LL, Tan YM, Cheow PC, Chow P, Chan CY, Lim KH, Yerian L, Hsi E, Toh HC, Saunthararajah Y Enane FO, Shuen WH, Gu X, Quteba E, Przychodzen B, Makishima H, Bodo J, Ng J, Chee CL, Ba R, Seng Koh L, Lim J, Cheong R, Teo M, Hu Z, Ng KP, Maciejewski J, Radivoyevitch T, Chung A, Ooi LL, Tan YM, Cheow PC, Chow P, Chan CY, Lim KH, Yerian L, Hsi E, Toh HC, Saunthararajah Y GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition. The Journal of clinical investigation, 127, 9, 3527-3542 The Journal of clinical investigation, 127, 9, 3527-3542 The Journal of clinical investigation, 127, 9, 3527-3542 2017/09 Refereed Disclose to all
Makishima H Makishima H Makishima H Somatic SETBP1 mutations in myeloid neoplasms. Somatic SETBP1 mutations in myeloid neoplasms. Somatic SETBP1 mutations in myeloid neoplasms. International journal of hematology, 105, 6, 732-742 International journal of hematology, 105, 6, 732-742 International journal of hematology, 105, 6, 732-742 2017/06 Refereed Disclose to all
Hirsch CM, Przychodzen BP, Radivoyevitch T, Patel B, Thota S, Clemente MJ, Nagata Y, LaFramboise T, Carraway HE, Nazha A, Sekeres MA, Makishima H, Maciejewski JP Hirsch CM, Przychodzen BP, Radivoyevitch T, Patel B, Thota S, Clemente MJ, Nagata Y, LaFramboise T, Carraway HE, Nazha A, Sekeres MA, Makishima H, Maciejewski JP Hirsch CM, Przychodzen BP, Radivoyevitch T, Patel B, Thota S, Clemente MJ, Nagata Y, LaFramboise T, Carraway HE, Nazha A, Sekeres MA, Makishima H, Maciejewski JP Molecular features of early onset adult myelodysplastic syndrome. Molecular features of early onset adult myelodysplastic syndrome. Molecular features of early onset adult myelodysplastic syndrome. Haematologica, 102, 6, 1028-1034 Haematologica, 102, 6, 1028-1034 Haematologica, 102, 6, 1028-1034 2017/06 Refereed Disclose to all
Jobe F, Patel B, Kuzmanovic T, Makishima H, Yang Y, Przychodzen B, Hutchison RE, Bence KK, Maciejewski JP, Mohi G Jobe F, Patel B, Kuzmanovic T, Makishima H, Yang Y, Przychodzen B, Hutchison RE, Bence KK, Maciejewski JP, Mohi G Jobe F, Patel B, Kuzmanovic T, Makishima H, Yang Y, Przychodzen B, Hutchison RE, Bence KK, Maciejewski JP, Mohi G Deletion of Ptpn1 induces myeloproliferative neoplasm. Deletion of Ptpn1 induces myeloproliferative neoplasm. Deletion of Ptpn1 induces myeloproliferative neoplasm. Leukemia, 31, 5, 1229-1234 Leukemia, 31, 5, 1229-1234 Leukemia, 31, 5, 1229-1234 2017/05 Refereed Disclose to all
Pan F, Wingo TS, Zhao Z, Gao R, Makishima H, Qu G, Lin L, Yu M, Ortega JR, Wang J, Nazha A, Chen L, Yao B, Liu C, Chen S, Weeks O, Ni H, Phillips BL, Huang S, Wang J, He C, Li GM, Radivoyevitch T, Aifantis I, Maciejewski JP, Yang FC, Jin P, Xu M Pan F, Wingo TS, Zhao Z, Gao R, Makishima H, Qu G, Lin L, Yu M, Ortega JR, Wang J, Nazha A, Chen L, Yao B, Liu C, Chen S, Weeks O, Ni H, Phillips BL, Huang S, Wang J, He C, Li GM, Radivoyevitch T, Aifantis I, Maciejewski JP, Yang FC, Jin P, Xu M Pan F, Wingo TS, Zhao Z, Gao R, Makishima H, Qu G, Lin L, Yu M, Ortega JR, Wang J, Nazha A, Chen L, Yao B, Liu C, Chen S, Weeks O, Ni H, Phillips BL, Huang S, Wang J, He C, Li GM, Radivoyevitch T, Aifantis I, Maciejewski JP, Yang FC, Jin P, Xu M Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells. Nature communications, 8, 15102 Nature communications, 8, 15102 Nature communications, 8, 15102 2017/04 Refereed Disclose to all
Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood, 129, 17, 2347-2358 Blood, 129, 17, 2347-2358 Blood, 129, 17, 2347-2358 2017/04 Refereed Disclose to all
Stanley RF, Piszczatowski RT, Bartholdy B, Mitchell K, McKimpson WM, Narayanagari S, Walter D, Todorova TI, Hirsch C, Makishima H, Will B, McMahon C, Gritsman K, Maciejewski JP, Kitsis RN, Steidl U Stanley RF, Piszczatowski RT, Bartholdy B, Mitchell K, McKimpson WM, Narayanagari S, Walter D, Todorova TI, Hirsch C, Makishima H, Will B, McMahon C, Gritsman K, Maciejewski JP, Kitsis RN, Steidl U Stanley RF, Piszczatowski RT, Bartholdy B, Mitchell K, McKimpson WM, Narayanagari S, Walter D, Todorova TI, Hirsch C, Makishima H, Will B, McMahon C, Gritsman K, Maciejewski JP, Kitsis RN, Steidl U A myeloid tumor suppressor role for <i>NOL3</i>. A myeloid tumor suppressor role for <i>NOL3</i>. A myeloid tumor suppressor role for <i>NOL3</i>. The Journal of experimental medicine, 214, 3, 753-771 The Journal of experimental medicine, 214, 3, 753-771 The Journal of experimental medicine, 214, 3, 753-771 2017/03 Refereed Disclose to all
Makishima H, Yoshizato T, Yoshida K, Sekeres MA, Radivoyevitch T, Suzuki H, Przychodzen B, Nagata Y, Meggendorfer M, Sanada M, Okuno Y, Hirsch C, Kuzmanovic T, Sato Y, Sato-Otsubo A, LaFramboise T, Hosono N, Shiraishi Y, Chiba K, Haferlach C, Kern W, Tanaka H, Shiozawa Y, Gómez-Seguí I, Husseinzadeh HD, Thota S, Guinta KM, Dienes B, Nakamaki T, Miyawaki S, Saunthararajah Y, Chiba S, Miyano S, Shih LY, Haferlach T, Ogawa S, Maciejewski JP Makishima H, Yoshizato T, Yoshida K, Sekeres MA, Radivoyevitch T, Suzuki H, Przychodzen B, Nagata Y, Meggendorfer M, Sanada M, Okuno Y, Hirsch C, Kuzmanovic T, Sato Y, Sato-Otsubo A, LaFramboise T, Hosono N, Shiraishi Y, Chiba K, Haferlach C, Kern W, Tanaka H, Shiozawa Y, Gómez-Seguí I, Husseinzadeh HD, Thota S, Guinta KM, Dienes B, Nakamaki T, Miyawaki S, Saunthararajah Y, Chiba S, Miyano S, Shih LY, Haferlach T, Ogawa S, Maciejewski JP Makishima H, Yoshizato T, Yoshida K, Sekeres MA, Radivoyevitch T, Suzuki H, Przychodzen B, Nagata Y, Meggendorfer M, Sanada M, Okuno Y, Hirsch C, Kuzmanovic T, Sato Y, Sato-Otsubo A, LaFramboise T, Hosono N, Shiraishi Y, Chiba K, Haferlach C, Kern W, Tanaka H, Shiozawa Y, Gómez-Seguí I, Husseinzadeh HD, Thota S, Guinta KM, Dienes B, Nakamaki T, Miyawaki S, Saunthararajah Y, Chiba S, Miyano S, Shih LY, Haferlach T, Ogawa S, Maciejewski JP Dynamics of clonal evolution in myelodysplastic syndromes. Dynamics of clonal evolution in myelodysplastic syndromes. Dynamics of clonal evolution in myelodysplastic syndromes. Nature genetics, 49, 2, 204-212 Nature genetics, 49, 2, 204-212 Nature genetics, 49, 2, 204-212 2017/02 Refereed Disclose to all
Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, LaFramboise T, Polprasert C, Clemente MJ, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Cui E, Verma AK, McDevitt MA, List AF, Saunthararajah Y, Sekeres MA, Boultwood J, Ogawa S, Maciejewski JP Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, LaFramboise T, Polprasert C, Clemente MJ, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Cui E, Verma AK, McDevitt MA, List AF, Saunthararajah Y, Sekeres MA, Boultwood J, Ogawa S, Maciejewski JP Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, LaFramboise T, Polprasert C, Clemente MJ, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Cui E, Verma AK, McDevitt MA, List AF, Saunthararajah Y, Sekeres MA, Boultwood J, Ogawa S, Maciejewski JP Recurrent genetic defects on chromosome 5q in myeloid neoplasms. Recurrent genetic defects on chromosome 5q in myeloid neoplasms. Recurrent genetic defects on chromosome 5q in myeloid neoplasms. Oncotarget, 8, 4, 6483-6495 Oncotarget, 8, 4, 6483-6495 Oncotarget, 8, 4, 6483-6495 2017/01 Refereed Disclose to all
Makishima H Makishima H Makishima H Sequential acquisition of mutations in myelodysplastic syndromes. Sequential acquisition of mutations in myelodysplastic syndromes. Sequential acquisition of mutations in myelodysplastic syndromes. [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 10, 1828-1837 [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 10, 1828-1837 [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 10, 1828-1837 2017 Refereed Disclose to all
Mitani K, Nagata Y, Sasaki K, Yoshida K, Chiba K, Tanaka H, Shiraishi Y, Miyano S, Makishima H, Nakamura Y, Nakamura Y, Ichikawa M, Ogawa S Mitani K, Nagata Y, Sasaki K, Yoshida K, Chiba K, Tanaka H, Shiraishi Y, Miyano S, Makishima H, Nakamura Y, Nakamura Y, Ichikawa M, Ogawa S Mitani K, Nagata Y, Sasaki K, Yoshida K, Chiba K, Tanaka H, Shiraishi Y, Miyano S, Makishima H, Nakamura Y, Nakamura Y, Ichikawa M, Ogawa S Somatic mosaicism in chronic myeloid leukemia in remission. Somatic mosaicism in chronic myeloid leukemia in remission. Somatic mosaicism in chronic myeloid leukemia in remission. Blood, 128, 24, 2863-2866 Blood, 128, 24, 2863-2866 Blood, 128, 24, 2863-2866 2016/12 Refereed Disclose to all
Negoro E, Radivoyevitch T, Polprasert C, Adema V, Hosono N, Makishima H, Przychodzen B, Hirsch C, Clemente MJ, Nazha A, Santini V, McGraw KL, List AF, Sole F, Sekeres MA, Maciejewski JP Negoro E, Radivoyevitch T, Polprasert C, Adema V, Hosono N, Makishima H, Przychodzen B, Hirsch C, Clemente MJ, Nazha A, Santini V, McGraw KL, List AF, Sole F, Sekeres MA, Maciejewski JP Negoro E, Radivoyevitch T, Polprasert C, Adema V, Hosono N, Makishima H, Przychodzen B, Hirsch C, Clemente MJ, Nazha A, Santini V, McGraw KL, List AF, Sole F, Sekeres MA, Maciejewski JP Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide. Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide. Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide. Leukemia, 30, 12, 2405-2409 Leukemia, 30, 12, 2405-2409 Leukemia, 30, 12, 2405-2409 2016/12 Refereed Disclose to all
Mori T, Nagata Y, Makishima H, Sanada M, Shiozawa Y, Kon A, Yoshizato T, Sato-Otsubo A, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ishiyama K, Miyawaki S, Mori H, Nakamaki T, Kihara R, Kiyoi H, Koeffler HP, Shih LY, Miyano S, Naoe T, Haferlach C, Kern W, Haferlach T, Ogawa S, Yoshida K Mori T, Nagata Y, Makishima H, Sanada M, Shiozawa Y, Kon A, Yoshizato T, Sato-Otsubo A, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ishiyama K, Miyawaki S, Mori H, Nakamaki T, Kihara R, Kiyoi H, Koeffler HP, Shih LY, Miyano S, Naoe T, Haferlach C, Kern W, Haferlach T, Ogawa S, Yoshida K Mori T, Nagata Y, Makishima H, Sanada M, Shiozawa Y, Kon A, Yoshizato T, Sato-Otsubo A, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ishiyama K, Miyawaki S, Mori H, Nakamaki T, Kihara R, Kiyoi H, Koeffler HP, Shih LY, Miyano S, Naoe T, Haferlach C, Kern W, Haferlach T, Ogawa S, Yoshida K Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms. Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms. Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms. Leukemia, 30, 11, 2270-2273 Leukemia, 30, 11, 2270-2273 Leukemia, 30, 11, 2270-2273 2016/11 Refereed Disclose to all
Botezatu L, Michel LC, Helness A, Vadnais C, Makishima H, Hönes JM, Robert F, Vassen L, Thivakaran A, Al-Matary Y, Lams RF, Schütte J, Giebel B, Görgens A, Heuser M, Medyouf H, Maciejewski J, Dührsen U, Möröy T, Khandanpour C Botezatu L, Michel LC, Helness A, Vadnais C, Makishima H, Hönes JM, Robert F, Vassen L, Thivakaran A, Al-Matary Y, Lams RF, Schütte J, Giebel B, Görgens A, Heuser M, Medyouf H, Maciejewski J, Dührsen U, Möröy T, Khandanpour C Botezatu L, Michel LC, Helness A, Vadnais C, Makishima H, Hönes JM, Robert F, Vassen L, Thivakaran A, Al-Matary Y, Lams RF, Schütte J, Giebel B, Görgens A, Heuser M, Medyouf H, Maciejewski J, Dührsen U, Möröy T, Khandanpour C Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML. Experimental hematology, 44, 8, 713-726.e14 Experimental hematology, 44, 8, 713-726.e14 Experimental hematology, 44, 8, 713-726.e14 2016/08 Refereed Disclose to all
Botezatu L, Michel LC, Makishima H, Schroeder T, Germing U, Haas R, van der Reijden B, Marneth AE, Bergevoet SM, Jansen JH, Przychodzen B, Wlodarski M, Niemeyer C, Platzbecker U, Ehninger G, Unnikrishnan A, Beck D, Pimanda J, Hellström-Lindberg E, Malcovati L, Boultwood J, Pellagatti A, Papaemmanuil E, Le Coutre P, Kaeda J, Opalka B, Möröy T, Dührsen U, Maciejewski J, Khandanpour C Botezatu L, Michel LC, Makishima H, Schroeder T, Germing U, Haas R, van der Reijden B, Marneth AE, Bergevoet SM, Jansen JH, Przychodzen B, Wlodarski M, Niemeyer C, Platzbecker U, Ehninger G, Unnikrishnan A, Beck D, Pimanda J, Hellström-Lindberg E, Malcovati L, Boultwood J, Pellagatti A, Papaemmanuil E, Le Coutre P, Kaeda J, Opalka B, Möröy T, Dührsen U, Maciejewski J, Khandanpour C Botezatu L, Michel LC, Makishima H, Schroeder T, Germing U, Haas R, van der Reijden B, Marneth AE, Bergevoet SM, Jansen JH, Przychodzen B, Wlodarski M, Niemeyer C, Platzbecker U, Ehninger G, Unnikrishnan A, Beck D, Pimanda J, Hellström-Lindberg E, Malcovati L, Boultwood J, Pellagatti A, Papaemmanuil E, Le Coutre P, Kaeda J, Opalka B, Möröy T, Dührsen U, Maciejewski J, Khandanpour C GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome. GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome. GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome. Experimental hematology, 44, 7, 590-595.e1 Experimental hematology, 44, 7, 590-595.e1 Experimental hematology, 44, 7, 590-595.e1 2016/07 Refereed Disclose to all
Hönes JM, Botezatu L, Helness A, Vadnais C, Vassen L, Robert F, Hergenhan SM, Thivakaran A, Schütte J, Al-Matary YS, Lams RF, Fraszscak J, Makishima H, Radivoyevitch T, Przychodzen B, da Conceição Castro SV, Görgens A, Giebel B, Klein-Hitpass L, Lennartz K, Heuser M, Thiede C, Ehninger G, Dührsen U, Maciejewski JP, Möröy T, Khandanpour C Hönes JM, Botezatu L, Helness A, Vadnais C, Vassen L, Robert F, Hergenhan SM, Thivakaran A, Schütte J, Al-Matary YS, Lams RF, Fraszscak J, Makishima H, Radivoyevitch T, Przychodzen B, da Conceição Castro SV, Görgens A, Giebel B, Klein-Hitpass L, Lennartz K, Heuser M, Thiede C, Ehninger G, Dührsen U, Maciejewski JP, Möröy T, Khandanpour C Hönes JM, Botezatu L, Helness A, Vadnais C, Vassen L, Robert F, Hergenhan SM, Thivakaran A, Schütte J, Al-Matary YS, Lams RF, Fraszscak J, Makishima H, Radivoyevitch T, Przychodzen B, da Conceição Castro SV, Görgens A, Giebel B, Klein-Hitpass L, Lennartz K, Heuser M, Thiede C, Ehninger G, Dührsen U, Maciejewski JP, Möröy T, Khandanpour C GFI1 as a novel prognostic and therapeutic factor for AML/MDS. GFI1 as a novel prognostic and therapeutic factor for AML/MDS. GFI1 as a novel prognostic and therapeutic factor for AML/MDS. Leukemia, 30, 6, 1237-1245 Leukemia, 30, 6, 1237-1245 Leukemia, 30, 6, 1237-1245 2016/06 Refereed Disclose to all
Hamilton BK, Visconte V, Jia X, Tabarroki A, Makishima H, Hasrouni E, Abounader D, Kalaycio M, Sekeres MA, Sobecks R, Duong Liu H, Bolwell B, Maciejewski JP, Copelan E, Tiu RV Hamilton BK, Visconte V, Jia X, Tabarroki A, Makishima H, Hasrouni E, Abounader D, Kalaycio M, Sekeres MA, Sobecks R, Duong Liu H, Bolwell B, Maciejewski JP, Copelan E, Tiu RV Hamilton BK, Visconte V, Jia X, Tabarroki A, Makishima H, Hasrouni E, Abounader D, Kalaycio M, Sekeres MA, Sobecks R, Duong Liu H, Bolwell B, Maciejewski JP, Copelan E, Tiu RV Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. American journal of hematology, 91, 4, 406-409 American journal of hematology, 91, 4, 406-409 American journal of hematology, 91, 4, 406-409 2016/06 Refereed Disclose to all
Ondrejka SL, Grzywacz B, Bodo J, Makishima H, Polprasert C, Said JW, Przychodzen B, Maciejewski JP, Hsi ED Ondrejka SL, Grzywacz B, Bodo J, Makishima H, Polprasert C, Said JW, Przychodzen B, Maciejewski JP, Hsi ED Ondrejka SL, Grzywacz B, Bodo J, Makishima H, Polprasert C, Said JW, Przychodzen B, Maciejewski JP, Hsi ED Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features. The American journal of surgical pathology, 40, 3, 335-341 The American journal of surgical pathology, 40, 3, 335-341 The American journal of surgical pathology, 40, 3, 335-341 2016/03 Refereed Disclose to all
Vishwakarma BA, Nguyen N, Makishima H, Hosono N, Gudmundsson KO, Negi V, Oakley K, Han Y, Przychodzen B, Maciejewski JP, Du Y Vishwakarma BA, Nguyen N, Makishima H, Hosono N, Gudmundsson KO, Negi V, Oakley K, Han Y, Przychodzen B, Maciejewski JP, Du Y Vishwakarma BA, Nguyen N, Makishima H, Hosono N, Gudmundsson KO, Negi V, Oakley K, Han Y, Przychodzen B, Maciejewski JP, Du Y Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Leukemia, 30, 1, 200-208 Leukemia, 30, 1, 200-208 Leukemia, 30, 1, 200-208 2016/01 Refereed Disclose to all
Makishima H, Ogawa S Makishima H, Ogawa S Makishima H, Ogawa S Gene mutations in myelodysplastic syndromes. Gene mutations in myelodysplastic syndromes. Gene mutations in myelodysplastic syndromes. [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 12, 2543-2553 [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 12, 2543-2553 [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 12, 2543-2553 2016 Refereed Disclose to all
Yoshizato T, Makishima H Yoshizato T, Makishima H Yoshizato T, Makishima H Gene mutations in bone marrow failure syndromes. Gene mutations in bone marrow failure syndromes. Gene mutations in bone marrow failure syndromes. [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 12, 2519-2525 [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 12, 2519-2525 [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 12, 2519-2525 2016 Refereed Disclose to all
Ruffalo M, Husseinzadeh H, Makishima H, Przychodzen B, Ashkar M, Koyutürk M, Maciejewski JP, LaFramboise T Ruffalo M, Husseinzadeh H, Makishima H, Przychodzen B, Ashkar M, Koyutürk M, Maciejewski JP, LaFramboise T Ruffalo M, Husseinzadeh H, Makishima H, Przychodzen B, Ashkar M, Koyutürk M, Maciejewski JP, LaFramboise T Whole-exome sequencing enhances prognostic classification of myeloid malignancies. Whole-exome sequencing enhances prognostic classification of myeloid malignancies. Whole-exome sequencing enhances prognostic classification of myeloid malignancies. Journal of biomedical informatics, 58, 104-113 Journal of biomedical informatics, 58, 104-113 Journal of biomedical informatics, 58, 104-113 2015/12 Refereed Disclose to all
Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S Integrated molecular analysis of adult T cell leukemia/lymphoma. Integrated molecular analysis of adult T cell leukemia/lymphoma. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nature genetics, 47, 11, 1304-1315 Nature genetics, 47, 11, 1304-1315 Nature genetics, 47, 11, 1304-1315 2015/11 Refereed Disclose to all
Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, Reif AJ, Schmidt SJ, Qi H, Zhao H, Joberty G, Faelth-Savitski M, Bantscheff M, Drewes G, Duraiswami C, Brady P, Groy A, Narayanagari SR, Antony-Debre I, Mitchell K, Wang HR, Kao YR, Christopeit M, Carvajal L, Barreyro L, Paietta E, Makishima H, Will B, Concha N, Adams ND, Schwartz B, McCabe MT, Maciejewski J, Verma A, Steidl U Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, Reif AJ, Schmidt SJ, Qi H, Zhao H, Joberty G, Faelth-Savitski M, Bantscheff M, Drewes G, Duraiswami C, Brady P, Groy A, Narayanagari SR, Antony-Debre I, Mitchell K, Wang HR, Kao YR, Christopeit M, Carvajal L, Barreyro L, Paietta E, Makishima H, Will B, Concha N, Adams ND, Schwartz B, McCabe MT, Maciejewski J, Verma A, Steidl U Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, Reif AJ, Schmidt SJ, Qi H, Zhao H, Joberty G, Faelth-Savitski M, Bantscheff M, Drewes G, Duraiswami C, Brady P, Groy A, Narayanagari SR, Antony-Debre I, Mitchell K, Wang HR, Kao YR, Christopeit M, Carvajal L, Barreyro L, Paietta E, Makishima H, Will B, Concha N, Adams ND, Schwartz B, McCabe MT, Maciejewski J, Verma A, Steidl U New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nature chemical biology, 11, 11, 878-886 Nature chemical biology, 11, 11, 878-886 Nature chemical biology, 11, 11, 878-886 2015/11 Refereed Disclose to all
Nazha A, Seastone D, Radivoyevitch T, Przychodzen B, Carraway HE, Patel BJ, Carew J, Makishima H, Sekeres MA, Maciejewski JP Nazha A, Seastone D, Radivoyevitch T, Przychodzen B, Carraway HE, Patel BJ, Carew J, Makishima H, Sekeres MA, Maciejewski JP Nazha A, Seastone D, Radivoyevitch T, Przychodzen B, Carraway HE, Patel BJ, Carew J, Makishima H, Sekeres MA, Maciejewski JP Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes. Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes. Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes. Haematologica, 100, 11, e434-7 Haematologica, 100, 11, e434-7 Haematologica, 100, 11, e434-7 2015/11 Refereed Disclose to all
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, Hirsh C, Viny AD, Hosano N, Bleeker FE, Meggendorfer M, Alpermann T, Shiraishi Y, Chiba K, Tanaka H, van Noorden CJ, Radivoyevitch T, Carraway HE, Makishima H, Miyano S, Sekeres MA, Ogawa S, Haferlach T, Maciejewski JP Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, Hirsh C, Viny AD, Hosano N, Bleeker FE, Meggendorfer M, Alpermann T, Shiraishi Y, Chiba K, Tanaka H, van Noorden CJ, Radivoyevitch T, Carraway HE, Makishima H, Miyano S, Sekeres MA, Ogawa S, Haferlach T, Maciejewski JP Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, Hirsh C, Viny AD, Hosano N, Bleeker FE, Meggendorfer M, Alpermann T, Shiraishi Y, Chiba K, Tanaka H, van Noorden CJ, Radivoyevitch T, Carraway HE, Makishima H, Miyano S, Sekeres MA, Ogawa S, Haferlach T, Maciejewski JP Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms. Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms. Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms. Leukemia, 29, 11, 2134-2142 Leukemia, 29, 11, 2134-2142 Leukemia, 29, 11, 2134-2142 2015/11 Refereed Disclose to all
Wang X, Muramatsu H, Okuno Y, Sakaguchi H, Yoshida K, Kawashima N, Xu Y, Shiraishi Y, Chiba K, Tanaka H, Saito S, Nakazawa Y, Masunari T, Hirose T, Elmahdi S, Narita A, Doisaki S, Ismael O, Makishima H, Hama A, Miyano S, Takahashi Y, Ogawa S, Kojima S Wang X, Muramatsu H, Okuno Y, Sakaguchi H, Yoshida K, Kawashima N, Xu Y, Shiraishi Y, Chiba K, Tanaka H, Saito S, Nakazawa Y, Masunari T, Hirose T, Elmahdi S, Narita A, Doisaki S, Ismael O, Makishima H, Hama A, Miyano S, Takahashi Y, Ogawa S, Kojima S Wang X, Muramatsu H, Okuno Y, Sakaguchi H, Yoshida K, Kawashima N, Xu Y, Shiraishi Y, Chiba K, Tanaka H, Saito S, Nakazawa Y, Masunari T, Hirose T, Elmahdi S, Narita A, Doisaki S, Ismael O, Makishima H, Hama A, Miyano S, Takahashi Y, Ogawa S, Kojima S GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica, 100, 10, e398-401 Haematologica, 100, 10, e398-401 Haematologica, 100, 10, e398-401 2015/10 Refereed Disclose to all
Huang D, Nagata Y, Grossmann V, Radivoyevitch T, Okuno Y, Nagae G, Hosono N, Schnittger S, Sanada M, Przychodzen B, Kon A, Polprasert C, Shen W, Clemente MJ, Phillips JG, Alpermann T, Yoshida K, Nadarajah N, Sekeres MA, Oakley K, Nguyen N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Miyano S, Haferlach C, Kern W, Haferlach T, Du Y, Ogawa S, Makishima H Huang D, Nagata Y, Grossmann V, Radivoyevitch T, Okuno Y, Nagae G, Hosono N, Schnittger S, Sanada M, Przychodzen B, Kon A, Polprasert C, Shen W, Clemente MJ, Phillips JG, Alpermann T, Yoshida K, Nadarajah N, Sekeres MA, Oakley K, Nguyen N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Miyano S, Haferlach C, Kern W, Haferlach T, Du Y, Ogawa S, Makishima H Huang D, Nagata Y, Grossmann V, Radivoyevitch T, Okuno Y, Nagae G, Hosono N, Schnittger S, Sanada M, Przychodzen B, Kon A, Polprasert C, Shen W, Clemente MJ, Phillips JG, Alpermann T, Yoshida K, Nadarajah N, Sekeres MA, Oakley K, Nguyen N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Miyano S, Haferlach C, Kern W, Haferlach T, Du Y, Ogawa S, Makishima H BRCC3 mutations in myeloid neoplasms. BRCC3 mutations in myeloid neoplasms. BRCC3 mutations in myeloid neoplasms. Haematologica, 100, 8, 1051-1057 Haematologica, 100, 8, 1051-1057 Haematologica, 100, 8, 1051-1057 2015/08 Refereed Disclose to all
Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, Sato-Otsubo A, Sato Y, Liu D, Suzuki H, Wu CO, Shiraishi Y, Clemente MJ, Kataoka K, Shiozawa Y, Okuno Y, Chiba K, Tanaka H, Nagata Y, Katagiri T, Kon A, Sanada M, Scheinberg P, Miyano S, Maciejewski JP, Nakao S, Young NS, Ogawa S Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, Sato-Otsubo A, Sato Y, Liu D, Suzuki H, Wu CO, Shiraishi Y, Clemente MJ, Kataoka K, Shiozawa Y, Okuno Y, Chiba K, Tanaka H, Nagata Y, Katagiri T, Kon A, Sanada M, Scheinberg P, Miyano S, Maciejewski JP, Nakao S, Young NS, Ogawa S Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, Sato-Otsubo A, Sato Y, Liu D, Suzuki H, Wu CO, Shiraishi Y, Clemente MJ, Kataoka K, Shiozawa Y, Okuno Y, Chiba K, Tanaka H, Nagata Y, Katagiri T, Kon A, Sanada M, Scheinberg P, Miyano S, Maciejewski JP, Nakao S, Young NS, Ogawa S Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. The New England journal of medicine, 373, 1, 35-47 The New England journal of medicine, 373, 1, 35-47 The New England journal of medicine, 373, 1, 35-47 2015/07 Refereed Disclose to all
Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, Singh J, Padgett RA, Gu X, Phillips JG, Clemente M, Parker Y, Lindner D, Dienes B, Jankowsky E, Saunthararajah Y, Du Y, Oakley K, Nguyen N, Mukherjee S, Pabst C, Godley LA, Churpek JE, Pollyea DA, Krug U, Berdel WE, Klein HU, Dugas M, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Yoshida K, Ogawa S, Müller-Tidow C, Maciejewski JP Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, Singh J, Padgett RA, Gu X, Phillips JG, Clemente M, Parker Y, Lindner D, Dienes B, Jankowsky E, Saunthararajah Y, Du Y, Oakley K, Nguyen N, Mukherjee S, Pabst C, Godley LA, Churpek JE, Pollyea DA, Krug U, Berdel WE, Klein HU, Dugas M, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Yoshida K, Ogawa S, Müller-Tidow C, Maciejewski JP Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, Singh J, Padgett RA, Gu X, Phillips JG, Clemente M, Parker Y, Lindner D, Dienes B, Jankowsky E, Saunthararajah Y, Du Y, Oakley K, Nguyen N, Mukherjee S, Pabst C, Godley LA, Churpek JE, Pollyea DA, Krug U, Berdel WE, Klein HU, Dugas M, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Yoshida K, Ogawa S, Müller-Tidow C, Maciejewski JP Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Cancer cell, 27, 5, 658-670 Cancer cell, 27, 5, 658-670 Cancer cell, 27, 5, 658-670 2015/05 Refereed Disclose to all
Patel B, Hirsch C, Clemente M, Sekeres M, Makishima H, Maciejewski JP Patel B, Hirsch C, Clemente M, Sekeres M, Makishima H, Maciejewski JP Patel B, Hirsch C, Clemente M, Sekeres M, Makishima H, Maciejewski JP Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms. Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms. Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms. International journal of hematology, 101, 3, 213-218 International journal of hematology, 101, 3, 213-218 International journal of hematology, 101, 3, 213-218 2015/03 Refereed Disclose to all
Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Nature medicine, 21, 1, 71-75 Nature medicine, 21, 1, 71-75 Nature medicine, 21, 1, 71-75 2015/01 Refereed Disclose to all
Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, Nakashima M, Hsi ED, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Boultwood J, Makishima H, Maciejewski JP, Padgett RA Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, Nakashima M, Hsi ED, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Boultwood J, Makishima H, Maciejewski JP, Padgett RA Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, Nakashima M, Hsi ED, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Boultwood J, Makishima H, Maciejewski JP, Padgett RA PRPF8 defects cause missplicing in myeloid malignancies. PRPF8 defects cause missplicing in myeloid malignancies. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia, 29, 1, 126-136 Leukemia, 29, 1, 126-136 Leukemia, 29, 1, 126-136 2015/01 Refereed Disclose to all
Sakaguchi H, Muramatsu H, Okuno Y, Makishima H, Xu Y, Furukawa-Hibi Y, Wang X, Narita A, Yoshida K, Shiraishi Y, Doisaki S, Yoshida N, Hama A, Takahashi Y, Yamada K, Miyano S, Ogawa S, Maciejewski JP, Kojima S Sakaguchi H, Muramatsu H, Okuno Y, Makishima H, Xu Y, Furukawa-Hibi Y, Wang X, Narita A, Yoshida K, Shiraishi Y, Doisaki S, Yoshida N, Hama A, Takahashi Y, Yamada K, Miyano S, Ogawa S, Maciejewski JP, Kojima S Sakaguchi H, Muramatsu H, Okuno Y, Makishima H, Xu Y, Furukawa-Hibi Y, Wang X, Narita A, Yoshida K, Shiraishi Y, Doisaki S, Yoshida N, Hama A, Takahashi Y, Yamada K, Miyano S, Ogawa S, Maciejewski JP, Kojima S Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia. Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia. Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia. PloS one, 10, 12, e0145394 PloS one, 10, 12, e0145394 PloS one, 10, 12, e0145394 2015 Refereed Disclose to all
Shen W, Clemente MJ, Hosono N, Yoshida K, Przychodzen B, Yoshizato T, Shiraishi Y, Miyano S, Ogawa S, Maciejewski JP, Makishima H Shen W, Clemente MJ, Hosono N, Yoshida K, Przychodzen B, Yoshizato T, Shiraishi Y, Miyano S, Ogawa S, Maciejewski JP, Makishima H Shen W, Clemente MJ, Hosono N, Yoshida K, Przychodzen B, Yoshizato T, Shiraishi Y, Miyano S, Ogawa S, Maciejewski JP, Makishima H Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. The Journal of clinical investigation, 124, 10, 4529-4538 The Journal of clinical investigation, 124, 10, 4529-4538 The Journal of clinical investigation, 124, 10, 4529-4538 2014/10 Refereed Disclose to all
Fang J, Barker B, Bolanos L, Liu X, Jerez A, Makishima H, Christie S, Chen X, Rao DS, Grimes HL, Komurov K, Weirauch MT, Cancelas JA, Maciejewski JP, Starczynowski DT Fang J, Barker B, Bolanos L, Liu X, Jerez A, Makishima H, Christie S, Chen X, Rao DS, Grimes HL, Komurov K, Weirauch MT, Cancelas JA, Maciejewski JP, Starczynowski DT Fang J, Barker B, Bolanos L, Liu X, Jerez A, Makishima H, Christie S, Chen X, Rao DS, Grimes HL, Komurov K, Weirauch MT, Cancelas JA, Maciejewski JP, Starczynowski DT Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network. Cell reports, 8, 5, 1328-1338 Cell reports, 8, 5, 1328-1338 Cell reports, 8, 5, 1328-1338 2014/09 Refereed Disclose to all
Thota S, Viny AD, Makishima H, Spitzer B, Radivoyevitch T, Przychodzen B, Sekeres MA, Levine RL, Maciejewski JP Thota S, Viny AD, Makishima H, Spitzer B, Radivoyevitch T, Przychodzen B, Sekeres MA, Levine RL, Maciejewski JP Thota S, Viny AD, Makishima H, Spitzer B, Radivoyevitch T, Przychodzen B, Sekeres MA, Levine RL, Maciejewski JP Genetic alterations of the cohesin complex genes in myeloid malignancies. Genetic alterations of the cohesin complex genes in myeloid malignancies. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood, 124, 11, 1790-1798 Blood, 124, 11, 1790-1798 Blood, 124, 11, 1790-1798 2014/09 Refereed Disclose to all
Makishima H Makishima H Makishima H [Identification of new leukemogenesis-related genes on chromosome 7 in myeloid neoplasms by next generation sequencing]. [Identification of new leukemogenesis-related genes on chromosome 7 in myeloid neoplasms by next generation sequencing]. [Identification of new leukemogenesis-related genes on chromosome 7 in myeloid neoplasms by next generation sequencing]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 7, 751-757 [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 7, 751-757 [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 7, 751-757 2014/07 Refereed Disclose to all
Hosono N, Makishima H, Jerez A, Yoshida K, Przychodzen B, McMahon S, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Gómez-Seguí I, Verma AK, McDevitt MA, Sekeres MA, Ogawa S, Maciejewski JP Hosono N, Makishima H, Jerez A, Yoshida K, Przychodzen B, McMahon S, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Gómez-Seguí I, Verma AK, McDevitt MA, Sekeres MA, Ogawa S, Maciejewski JP Hosono N, Makishima H, Jerez A, Yoshida K, Przychodzen B, McMahon S, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Gómez-Seguí I, Verma AK, McDevitt MA, Sekeres MA, Ogawa S, Maciejewski JP Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Leukemia, 28, 6, 1348-1351 Leukemia, 28, 6, 1348-1351 Leukemia, 28, 6, 1348-1351 2014/06 Refereed Disclose to all
Ly B, Modi A, Rogers HJ, Makishima H, Hanna R, Cook JR, Theil KS, Maciejewski JP Ly B, Modi A, Rogers HJ, Makishima H, Hanna R, Cook JR, Theil KS, Maciejewski JP Ly B, Modi A, Rogers HJ, Makishima H, Hanna R, Cook JR, Theil KS, Maciejewski JP Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS. Pediatric blood & cancer, 61, 5, 946-948 Pediatric blood & cancer, 61, 5, 946-948 Pediatric blood & cancer, 61, 5, 946-948 2014/05 Refereed Disclose to all
Ishida F, Matsuda K, Sekiguchi N, Makishima H, Taira C, Momose K, Nishina S, Senoo N, Sakai H, Ito T, Kwong YL Ishida F, Matsuda K, Sekiguchi N, Makishima H, Taira C, Momose K, Nishina S, Senoo N, Sakai H, Ito T, Kwong YL Ishida F, Matsuda K, Sekiguchi N, Makishima H, Taira C, Momose K, Nishina S, Senoo N, Sakai H, Ito T, Kwong YL STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia. Cancer science, 105, 3, 342-346 Cancer science, 105, 3, 342-346 Cancer science, 105, 3, 342-346 2014/03 Refereed Disclose to all
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia, 28, 1, 78-87 Leukemia, 28, 1, 78-87 Leukemia, 28, 1, 78-87 2014/01 Refereed Disclose to all
Nakazawa H, Makishima H, Ito T, Ota H, Momose K, Sekiguchi N, Yoshizawa K, Akamatsu T, Ishida F Nakazawa H, Makishima H, Ito T, Ota H, Momose K, Sekiguchi N, Yoshizawa K, Akamatsu T, Ishida F Nakazawa H, Makishima H, Ito T, Ota H, Momose K, Sekiguchi N, Yoshizawa K, Akamatsu T, Ishida F Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. International journal of medical sciences, 11, 8, 819-823 International journal of medical sciences, 11, 8, 819-823 International journal of medical sciences, 11, 8, 819-823 2014 Refereed Disclose to all
Mehta HM, Glaubach T, Long A, Lu H, Przychodzen B, Makishima H, McDevitt MA, Cross NC, Maciejewski J, Corey SJ Mehta HM, Glaubach T, Long A, Lu H, Przychodzen B, Makishima H, McDevitt MA, Cross NC, Maciejewski J, Corey SJ Mehta HM, Glaubach T, Long A, Lu H, Przychodzen B, Makishima H, McDevitt MA, Cross NC, Maciejewski J, Corey SJ Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling. Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling. Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling. Leukemia, 27, 12, 2407-2410 Leukemia, 27, 12, 2407-2410 Leukemia, 27, 12, 2407-2410 2013/12 Refereed Disclose to all
Menezes J, Makishima H, Gomez I, Acquadro F, Gómez-López G, Graña O, Dopazo A, Alvarez S, Trujillo M, Pisano DG, Maciejewski JP, Cigudosa JC Menezes J, Makishima H, Gomez I, Acquadro F, Gómez-López G, Graña O, Dopazo A, Alvarez S, Trujillo M, Pisano DG, Maciejewski JP, Cigudosa JC Menezes J, Makishima H, Gomez I, Acquadro F, Gómez-López G, Graña O, Dopazo A, Alvarez S, Trujillo M, Pisano DG, Maciejewski JP, Cigudosa JC CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. Blood cancer journal, 3, e158 Blood cancer journal, 3, e158 Blood cancer journal, 3, e158 2013/11 Refereed Disclose to all
Makishima H Makishima H Makishima H [Deep sequencing]. [Deep sequencing]. [Deep sequencing]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, 10, 1559-1565 [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, 10, 1559-1565 [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, 10, 1559-1565 2013/10 Refereed Disclose to all
Jerez A, Clemente MJ, Makishima H, Rajala H, Gómez-Seguí I, Olson T, McGraw K, Przychodzen B, Kulasekararaj A, Afable M, Husseinzadeh HD, Hosono N, LeBlanc F, Lagström S, Zhang D, Ellonen P, Tichelli A, Nissen C, Lichtin AE, Wodnar-Filipowicz A, Mufti GJ, List AF, Mustjoki S, Loughran TP Jr, Maciejewski JP Jerez A, Clemente MJ, Makishima H, Rajala H, Gómez-Seguí I, Olson T, McGraw K, Przychodzen B, Kulasekararaj A, Afable M, Husseinzadeh HD, Hosono N, LeBlanc F, Lagström S, Zhang D, Ellonen P, Tichelli A, Nissen C, Lichtin AE, Wodnar-Filipowicz A, Mufti GJ, List AF, Mustjoki S, Loughran TP Jr, Maciejewski JP Jerez A, Clemente MJ, Makishima H, Rajala H, Gómez-Seguí I, Olson T, McGraw K, Przychodzen B, Kulasekararaj A, Afable M, Husseinzadeh HD, Hosono N, LeBlanc F, Lagström S, Zhang D, Ellonen P, Tichelli A, Nissen C, Lichtin AE, Wodnar-Filipowicz A, Mufti GJ, List AF, Mustjoki S, Loughran TP Jr, Maciejewski JP STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. Blood, 122, 14, 2453-2459 Blood, 122, 14, 2453-2459 Blood, 122, 14, 2453-2459 2013/10 Refereed Disclose to all
Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. Haematologica, 98, 9, e105-7 Haematologica, 98, 9, e105-7 Haematologica, 98, 9, e105-7 2013/09 Refereed Disclose to all
Gómez-Seguí I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S, Shiraishi Y, Husseinzadeh HD, Guinta K, Clemente M, Hosono N, McDevitt MA, Moliterno AR, Sekeres MA, Ogawa S, Maciejewski JP Gómez-Seguí I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S, Shiraishi Y, Husseinzadeh HD, Guinta K, Clemente M, Hosono N, McDevitt MA, Moliterno AR, Sekeres MA, Ogawa S, Maciejewski JP Gómez-Seguí I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S, Shiraishi Y, Husseinzadeh HD, Guinta K, Clemente M, Hosono N, McDevitt MA, Moliterno AR, Sekeres MA, Ogawa S, Maciejewski JP Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Leukemia, 27, 9, 1943-1946 Leukemia, 27, 9, 1943-1946 Leukemia, 27, 9, 1943-1946 2013/09 Refereed Disclose to all
Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y, Ng KP, Gudmundsson KO, Vishwakarma BA, Jerez A, Gomez-Segui I, Takahashi M, Shiraishi Y, Nagata Y, Guinta K, Mori H, Sekeres MA, Chiba K, Tanaka H, Muramatsu H, Sakaguchi H, Paquette RL, McDevitt MA, Kojima S, Saunthararajah Y, Miyano S, Shih LY, Du Y, Ogawa S, Maciejewski JP Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y, Ng KP, Gudmundsson KO, Vishwakarma BA, Jerez A, Gomez-Segui I, Takahashi M, Shiraishi Y, Nagata Y, Guinta K, Mori H, Sekeres MA, Chiba K, Tanaka H, Muramatsu H, Sakaguchi H, Paquette RL, McDevitt MA, Kojima S, Saunthararajah Y, Miyano S, Shih LY, Du Y, Ogawa S, Maciejewski JP Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y, Ng KP, Gudmundsson KO, Vishwakarma BA, Jerez A, Gomez-Segui I, Takahashi M, Shiraishi Y, Nagata Y, Guinta K, Mori H, Sekeres MA, Chiba K, Tanaka H, Muramatsu H, Sakaguchi H, Paquette RL, McDevitt MA, Kojima S, Saunthararajah Y, Miyano S, Shih LY, Du Y, Ogawa S, Maciejewski JP Somatic SETBP1 mutations in myeloid malignancies. Somatic SETBP1 mutations in myeloid malignancies. Somatic SETBP1 mutations in myeloid malignancies. Nature genetics, 45, 8, 942-946 Nature genetics, 45, 8, 942-946 Nature genetics, 45, 8, 942-946 2013/08 Refereed Disclose to all
Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nature genetics, 45, 8, 937-941 Nature genetics, 45, 8, 937-941 Nature genetics, 45, 8, 937-941 2013/08 Refereed Disclose to all
Przychodzen B, Jerez A, Guinta K, Sekeres MA, Padgett R, Maciejewski JP, Makishima H Przychodzen B, Jerez A, Guinta K, Sekeres MA, Padgett R, Maciejewski JP, Makishima H Przychodzen B, Jerez A, Guinta K, Sekeres MA, Padgett R, Maciejewski JP, Makishima H Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood, 122, 6, 999-1006 Blood, 122, 6, 999-1006 Blood, 122, 6, 999-1006 2013/08 Refereed Disclose to all
Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N, Hu Z, Cheriyath V, Vatolin S, Przychodzen B, Reu FJ, Saunthararajah Y, O'Keefe C, Sekeres MA, List AF, Moliterno AR, McDevitt MA, Maciejewski JP, Makishima H Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N, Hu Z, Cheriyath V, Vatolin S, Przychodzen B, Reu FJ, Saunthararajah Y, O'Keefe C, Sekeres MA, List AF, Moliterno AR, McDevitt MA, Maciejewski JP, Makishima H Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N, Hu Z, Cheriyath V, Vatolin S, Przychodzen B, Reu FJ, Saunthararajah Y, O'Keefe C, Sekeres MA, List AF, Moliterno AR, McDevitt MA, Maciejewski JP, Makishima H Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia, 27, 6, 1301-1309 Leukemia, 27, 6, 1301-1309 Leukemia, 27, 6, 1301-1309 2013/06 Refereed Disclose to all
Yang L, Mailloux A, Rollison DE, Painter JS, Maciejewski J, Paquette RL, Loughran TP, McGraw K, Makishima H, Radhakrishnan R, Wei S, Ren X, Komrokji R, List AF, Epling-Burnette PK Yang L, Mailloux A, Rollison DE, Painter JS, Maciejewski J, Paquette RL, Loughran TP, McGraw K, Makishima H, Radhakrishnan R, Wei S, Ren X, Komrokji R, List AF, Epling-Burnette PK Yang L, Mailloux A, Rollison DE, Painter JS, Maciejewski J, Paquette RL, Loughran TP, McGraw K, Makishima H, Radhakrishnan R, Wei S, Ren X, Komrokji R, List AF, Epling-Burnette PK Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency. Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency. Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency. Leukemia, 27, 4, 897-906 Leukemia, 27, 4, 897-906 Leukemia, 27, 4, 897-906 2013/04 Refereed Disclose to all
Kar SA, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, Tiu RV, Przychodzen B, Sakaguchi H, Kojima S, Sekeres MA, List AF, McDevitt MA, Maciejewski JP Kar SA, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, Tiu RV, Przychodzen B, Sakaguchi H, Kojima S, Sekeres MA, List AF, McDevitt MA, Maciejewski JP Kar SA, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, Tiu RV, Przychodzen B, Sakaguchi H, Kojima S, Sekeres MA, List AF, McDevitt MA, Maciejewski JP Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica, 98, 1, 107-113 Haematologica, 98, 1, 107-113 Haematologica, 98, 1, 107-113 2013/01 Refereed Disclose to all
Sekeres MA, Tiu RV, Komrokji R, Lancet J, Advani AS, Afable M, Englehaupt R, Juersivich J, Cuthbertson D, Paleveda J, Tabarroki A, Visconte V, Makishima H, Jerez A, Paquette R, List AF, Maciejewski JP Sekeres MA, Tiu RV, Komrokji R, Lancet J, Advani AS, Afable M, Englehaupt R, Juersivich J, Cuthbertson D, Paleveda J, Tabarroki A, Visconte V, Makishima H, Jerez A, Paquette R, List AF, Maciejewski JP Sekeres MA, Tiu RV, Komrokji R, Lancet J, Advani AS, Afable M, Englehaupt R, Juersivich J, Cuthbertson D, Paleveda J, Tabarroki A, Visconte V, Makishima H, Jerez A, Paquette R, List AF, Maciejewski JP Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Blood, 120, 25, 4945-4951 Blood, 120, 25, 4945-4951 Blood, 120, 25, 4945-4951 2012/12 Refereed Disclose to all
Sakaguchi H, Makishima H, Muramatsu H, Visconte V, Jerez A, Jankowska AM, Tiu RV, Maciejewski JP, Kojima S Sakaguchi H, Makishima H, Muramatsu H, Visconte V, Jerez A, Jankowska AM, Tiu RV, Maciejewski JP, Kojima S Sakaguchi H, Makishima H, Muramatsu H, Visconte V, Jerez A, Jankowska AM, Tiu RV, Maciejewski JP, Kojima S Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies. Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies. Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies. Leukemia research, 36, 12, e215-7 Leukemia research, 36, 12, e215-7 Leukemia research, 36, 12, e215-7 2012/12 Refereed Disclose to all
Visconte V, Makishima H, Maciejewski JP, Tiu RV Visconte V, Makishima H, Maciejewski JP, Tiu RV Visconte V, Makishima H, Maciejewski JP, Tiu RV Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia, 26, 12, 2447-2454 Leukemia, 26, 12, 2447-2454 Leukemia, 26, 12, 2447-2454 2012/12 Refereed Disclose to all
Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, Guinta K, Durkin L, Hsi ED, McGraw K, Zhang D, Wlodarski MW, Porkka K, Sekeres MA, List A, Mustjoki S, Loughran TP, Maciejewski JP Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, Guinta K, Durkin L, Hsi ED, McGraw K, Zhang D, Wlodarski MW, Porkka K, Sekeres MA, List A, Mustjoki S, Loughran TP, Maciejewski JP Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, Guinta K, Durkin L, Hsi ED, McGraw K, Zhang D, Wlodarski MW, Porkka K, Sekeres MA, List A, Mustjoki S, Loughran TP, Maciejewski JP STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood, 120, 15, 3048-3057 Blood, 120, 15, 3048-3057 Blood, 120, 15, 3048-3057 2012/10 Refereed Disclose to all
Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood, 120, 16, 3173-3186 Blood, 120, 16, 3173-3186 Blood, 120, 16, 3173-3186 2012/10 Refereed Disclose to all
Saito Y, Aoki Y, Muramatsu H, Makishima H, Maciejewski JP, Imaizumi M, Rikiishi T, Sasahara Y, Kure S, Niihori T, Tsuchiya S, Kojima S, Matsubara Y Saito Y, Aoki Y, Muramatsu H, Makishima H, Maciejewski JP, Imaizumi M, Rikiishi T, Sasahara Y, Kure S, Niihori T, Tsuchiya S, Kojima S, Matsubara Y Saito Y, Aoki Y, Muramatsu H, Makishima H, Maciejewski JP, Imaizumi M, Rikiishi T, Sasahara Y, Kure S, Niihori T, Tsuchiya S, Kojima S, Matsubara Y Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Leukemia research, 36, 8, 1009-1015 Leukemia research, 36, 8, 1009-1015 Leukemia research, 36, 8, 1009-1015 2012/08 Refereed Disclose to all
Makishima H, Sugimoto Y, Szpurka H, Clemente MJ, Ng KP, Muramatsu H, O'Keefe C, Saunthararajah Y, Maciejewski JP Makishima H, Sugimoto Y, Szpurka H, Clemente MJ, Ng KP, Muramatsu H, O'Keefe C, Saunthararajah Y, Maciejewski JP Makishima H, Sugimoto Y, Szpurka H, Clemente MJ, Ng KP, Muramatsu H, O'Keefe C, Saunthararajah Y, Maciejewski JP CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia, 26, 7, 1547-1554 Leukemia, 26, 7, 1547-1554 Leukemia, 26, 7, 1547-1554 2012/07 Refereed Disclose to all
Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B, Visconte V, Tiu RV, O'Keefe CL, Mohamedali AM, Kulasekararaj AG, Pellagatti A, McGraw K, Muramatsu H, Moliterno AR, Sekeres MA, McDevitt MA, Kojima S, List A, Boultwood J, Mufti GJ, Maciejewski JP Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B, Visconte V, Tiu RV, O'Keefe CL, Mohamedali AM, Kulasekararaj AG, Pellagatti A, McGraw K, Muramatsu H, Moliterno AR, Sekeres MA, McDevitt MA, Kojima S, List A, Boultwood J, Mufti GJ, Maciejewski JP Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B, Visconte V, Tiu RV, O'Keefe CL, Mohamedali AM, Kulasekararaj AG, Pellagatti A, McGraw K, Muramatsu H, Moliterno AR, Sekeres MA, McDevitt MA, Kojima S, List A, Boultwood J, Mufti GJ, Maciejewski JP Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood, 119, 25, 6109-6117 Blood, 119, 25, 6109-6117 Blood, 119, 25, 6109-6117 2012/06 Refereed Disclose to all
Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, O'Keefe CL, Mohamedali AM, Batista D, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, O'Keefe CL, Mohamedali AM, Batista D, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, O'Keefe CL, Mohamedali AM, Batista D, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30, 12, 1343-1349 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30, 12, 1343-1349 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30, 12, 1343-1349 2012/04 Refereed Disclose to all
Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood, 119, 14, 3203-3210 Blood, 119, 14, 3203-3210 Blood, 119, 14, 3203-3210 2012/04 Refereed Disclose to all
Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A, Jerez A, Szpurka H, O'Keefe CL, Guinta K, Afable M, Tiu R, McGraw KL, List AF, Maciejewski J Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A, Jerez A, Szpurka H, O'Keefe CL, Guinta K, Afable M, Tiu R, McGraw KL, List AF, Maciejewski J Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A, Jerez A, Szpurka H, O'Keefe CL, Guinta K, Afable M, Tiu R, McGraw KL, List AF, Maciejewski J Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. Journal of hematology & oncology, 5, 4 Journal of hematology & oncology, 5, 4 Journal of hematology & oncology, 5, 4 2012/03 Refereed Disclose to all
Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, Tiu RV Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, Tiu RV Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, Tiu RV SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia, 26, 3, 542-545 Leukemia, 26, 3, 542-545 Leukemia, 26, 3, 542-545 2012/03 Refereed Disclose to all
Muramatsu H, Makishima H, Maciejewski JP Muramatsu H, Makishima H, Maciejewski JP Muramatsu H, Makishima H, Maciejewski JP Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. Seminars in oncology, 39, 1, 67-73 Seminars in oncology, 39, 1, 67-73 Seminars in oncology, 39, 1, 67-73 2012/02 Refereed Disclose to all
Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, O'Keefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, O'Keefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, O'Keefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP Molecular lesions in childhood and adult acute megakaryoblastic leukaemia. Molecular lesions in childhood and adult acute megakaryoblastic leukaemia. Molecular lesions in childhood and adult acute megakaryoblastic leukaemia. British journal of haematology, 156, 3, 316-325 British journal of haematology, 156, 3, 316-325 British journal of haematology, 156, 3, 316-325 2012/02 Refereed Disclose to all
Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS, Duong HK, Copelan E, Kapur R, Olalla Saad ST, Maciejewski JP, Tiu RV Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS, Duong HK, Copelan E, Kapur R, Olalla Saad ST, Maciejewski JP, Tiu RV Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS, Duong HK, Copelan E, Kapur R, Olalla Saad ST, Maciejewski JP, Tiu RV Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PloS one, 7, 8, e43090 PloS one, 7, 8, e43090 PloS one, 7, 8, e43090 2012 Refereed Disclose to all
Clemente MJ, Wlodarski MW, Makishima H, Viny AD, Bretschneider I, Shaik M, Bejanyan N, Lichtin AE, Hsi ED, Paquette RL, Loughran TP Jr, Maciejewski JP Clemente MJ, Wlodarski MW, Makishima H, Viny AD, Bretschneider I, Shaik M, Bejanyan N, Lichtin AE, Hsi ED, Paquette RL, Loughran TP Jr, Maciejewski JP Clemente MJ, Wlodarski MW, Makishima H, Viny AD, Bretschneider I, Shaik M, Bejanyan N, Lichtin AE, Hsi ED, Paquette RL, Loughran TP Jr, Maciejewski JP Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood, 118, 16, 4384-4393 Blood, 118, 16, 4384-4393 Blood, 118, 16, 4384-4393 2011/10 Refereed Disclose to all
Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood, 118, 14, 3932-3941 Blood, 118, 14, 3932-3941 Blood, 118, 14, 3932-3941 2011/10 Refereed Disclose to all
Afable MG 2nd, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP Afable MG 2nd, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP Afable MG 2nd, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica, 96, 9, 1269-1275 Haematologica, 96, 9, 1269-1275 Haematologica, 96, 9, 1269-1275 2011/09 Refereed Disclose to all
Askar M, Sobecks R, Morishima Y, Kawase T, Nowacki A, Makishima H, Maciejewski J Askar M, Sobecks R, Morishima Y, Kawase T, Nowacki A, Makishima H, Maciejewski J Askar M, Sobecks R, Morishima Y, Kawase T, Nowacki A, Makishima H, Maciejewski J Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17, 9, 1409-1415 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17, 9, 1409-1415 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17, 9, 1409-1415 2011/09 Refereed Disclose to all
Ito T, Makishima H, Nakazawa H, Senoo Y, Senoo N, Ishida F Ito T, Makishima H, Nakazawa H, Senoo Y, Senoo N, Ishida F Ito T, Makishima H, Nakazawa H, Senoo Y, Senoo N, Ishida F Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT. Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT. Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT. Bone marrow transplantation, 46, 9, 1270-1271 Bone marrow transplantation, 46, 9, 1270-1271 Bone marrow transplantation, 46, 9, 1270-1271 2011/09 Refereed Disclose to all
Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood, 117, 25, 6876-6884 Blood, 117, 25, 6876-6884 Blood, 117, 25, 6876-6884 2011/06 Refereed Disclose to all
Makishima H, Maciejewski JP Makishima H, Maciejewski JP Makishima H, Maciejewski JP Pathogenesis and consequences of uniparental disomy in cancer. Pathogenesis and consequences of uniparental disomy in cancer. Pathogenesis and consequences of uniparental disomy in cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 12, 3913-3923 Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 12, 3913-3923 Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 12, 3913-3923 2011/06 Refereed Disclose to all
Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H, Przychodzen B, Prince C, Nicoll J, Siddaiah H, Shaik M, Szpurka H, Hsi E, Advani A, Paquette R, Maciejewski JP Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H, Przychodzen B, Prince C, Nicoll J, Siddaiah H, Shaik M, Szpurka H, Hsi E, Advani A, Paquette R, Maciejewski JP Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H, Przychodzen B, Prince C, Nicoll J, Siddaiah H, Shaik M, Szpurka H, Hsi E, Advani A, Paquette R, Maciejewski JP CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood, 117, 21, e198-206 Blood, 117, 21, e198-206 Blood, 117, 21, e198-206 2011/05 Refereed Disclose to all
Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z, Saunthararajah Y, Guinta K, Keddache MA, Putnam P, Sekeres MA, Moliterno AR, List AF, McDevitt MA, Maciejewski JP Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z, Saunthararajah Y, Guinta K, Keddache MA, Putnam P, Sekeres MA, Moliterno AR, List AF, McDevitt MA, Maciejewski JP Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z, Saunthararajah Y, Guinta K, Keddache MA, Putnam P, Sekeres MA, Moliterno AR, List AF, McDevitt MA, Maciejewski JP Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia, 24, 10, 1799-1804 Leukemia, 24, 10, 1799-1804 Leukemia, 24, 10, 1799-1804 2010/10 Refereed Disclose to all
Obama K, Makishima H, Ishida F Obama K, Makishima H, Ishida F Obama K, Makishima H, Ishida F Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population. Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population. Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population. Leukemia & lymphoma, 51, 8, 1580-1581 Leukemia & lymphoma, 51, 8, 1580-1581 Leukemia & lymphoma, 51, 8, 1580-1581 2010/08 Refereed Disclose to all
Szpurka H, Jankowska AM, Makishima H, Bodo J, Bejanyan N, Hsi ED, Sekeres MA, Maciejewski JP Szpurka H, Jankowska AM, Makishima H, Bodo J, Bejanyan N, Hsi ED, Sekeres MA, Maciejewski JP Szpurka H, Jankowska AM, Makishima H, Bodo J, Bejanyan N, Hsi ED, Sekeres MA, Maciejewski JP Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. Leukemia research, 34, 8, 969-973 Leukemia research, 34, 8, 969-973 Leukemia research, 34, 8, 969-973 2010/08 Refereed Disclose to all
Sugimoto Y, Muramatsu H, Makishima H, Prince C, Jankowska AM, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP Sugimoto Y, Muramatsu H, Makishima H, Prince C, Jankowska AM, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP Sugimoto Y, Muramatsu H, Makishima H, Prince C, Jankowska AM, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. British journal of haematology, 150, 1, 83-87 British journal of haematology, 150, 1, 83-87 British journal of haematology, 150, 1, 83-87 2010/07 Refereed Disclose to all
Fukuda T, Tsuchiya K, Makishima H, Tsuchiyama K, Mulchandani A, Kuroda K, Ueda M, Suye S Fukuda T, Tsuchiya K, Makishima H, Tsuchiyama K, Mulchandani A, Kuroda K, Ueda M, Suye S Fukuda T, Tsuchiya K, Makishima H, Tsuchiyama K, Mulchandani A, Kuroda K, Ueda M, Suye S Organophosphorus compound detection on a cell chip with yeast coexpressing hydrolase and eGFP. Organophosphorus compound detection on a cell chip with yeast coexpressing hydrolase and eGFP. Organophosphorus compound detection on a cell chip with yeast coexpressing hydrolase and eGFP. Biotechnology journal, 5, 5, 515-519 Biotechnology journal, 5, 5, 515-519 Biotechnology journal, 5, 5, 515-519 2010/05 Refereed Disclose to all
Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes, chromosomes & cancer, 49, 4, 390-399 Genes, chromosomes & cancer, 49, 4, 390-399 Genes, chromosomes & cancer, 49, 4, 390-399 2010/04 Refereed Disclose to all
Makishima H, Rataul M, Gondek LP, Huh J, Cook JR, Theil KS, Sekeres MA, Kuczkowski E, O'Keefe C, Maciejewski JP Makishima H, Rataul M, Gondek LP, Huh J, Cook JR, Theil KS, Sekeres MA, Kuczkowski E, O'Keefe C, Maciejewski JP Makishima H, Rataul M, Gondek LP, Huh J, Cook JR, Theil KS, Sekeres MA, Kuczkowski E, O'Keefe C, Maciejewski JP FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). Leukemia research, 34, 4, 447-453 Leukemia research, 34, 4, 447-453 Leukemia research, 34, 4, 447-453 2010/04 Refereed Disclose to all
Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Blood, 115, 10, 1969-1975 Blood, 115, 10, 1969-1975 Blood, 115, 10, 1969-1975 2010/03 Refereed Disclose to all
Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J, Muramatsu H, O'Keefe C, Hsi E, Paquette RL, Kojima S, List AF, Sekeres MA, McDevitt MA, Maciejewski JP Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J, Muramatsu H, O'Keefe C, Hsi E, Paquette RL, Kojima S, List AF, Sekeres MA, McDevitt MA, Maciejewski JP Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J, Muramatsu H, O'Keefe C, Hsi E, Paquette RL, Kojima S, List AF, Sekeres MA, McDevitt MA, Maciejewski JP Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, 36, 6109-6116 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, 36, 6109-6116 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, 36, 6109-6116 2009/12 Refereed Disclose to all
Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood, 113, 25, 6403-6410 Blood, 113, 25, 6403-6410 Blood, 113, 25, 6403-6410 2009/06 Refereed Disclose to all
Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang XF, McDevitt MA, Maciejewski JP Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang XF, McDevitt MA, Maciejewski JP Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang XF, McDevitt MA, Maciejewski JP 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer research, 68, 24, 10349-10357 Cancer research, 68, 24, 10349-10357 Cancer research, 68, 24, 10349-10357 2008/12 Refereed Disclose to all
Ito T, Makishima H, Nakazawa H, Kobayashi H, Shimodaira S, Nakazawa Y, Kitano K, Matsuda K, Hidaka E, Ishida F Ito T, Makishima H, Nakazawa H, Kobayashi H, Shimodaira S, Nakazawa Y, Kitano K, Matsuda K, Hidaka E, Ishida F Ito T, Makishima H, Nakazawa H, Kobayashi H, Shimodaira S, Nakazawa Y, Kitano K, Matsuda K, Hidaka E, Ishida F Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. European journal of haematology, 81, 2, 107-111 European journal of haematology, 81, 2, 107-111 European journal of haematology, 81, 2, 107-111 2008/08 Refereed Disclose to all
Makishima H Makishima H Makishima H [Analysis of chemokine receptor expression in aggressive NK-cell leukemia and chronic NK-cell lymphocytosis]. [Analysis of chemokine receptor expression in aggressive NK-cell leukemia and chronic NK-cell lymphocytosis]. [Analysis of chemokine receptor expression in aggressive NK-cell leukemia and chronic NK-cell lymphocytosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 1, 3-9 [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 1, 3-9 [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 1, 3-9 2008/01 Refereed Disclose to all
Makishima H, Komiyama Y, Asano N, Momose K, Nakamura S, Ishida F Makishima H, Komiyama Y, Asano N, Momose K, Nakamura S, Ishida F Makishima H, Komiyama Y, Asano N, Momose K, Nakamura S, Ishida F Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease. Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease. Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease. Internal medicine (Tokyo, Japan), 47, 4, 295-298 Internal medicine (Tokyo, Japan), 47, 4, 295-298 Internal medicine (Tokyo, Japan), 47, 4, 295-298 2008 Refereed Disclose to all
Makishima H, Ito T, Momose K, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Ichikawa N, Ueno M, Kobayashi H, Kitano K, Saito H, Kiyosawa K, Ishida F Makishima H, Ito T, Momose K, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Ichikawa N, Ueno M, Kobayashi H, Kitano K, Saito H, Kiyosawa K, Ishida F Makishima H, Ito T, Momose K, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Ichikawa N, Ueno M, Kobayashi H, Kitano K, Saito H, Kiyosawa K, Ishida F Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Leukemia research, 31, 9, 1237-1245 Leukemia research, 31, 9, 1237-1245 Leukemia research, 31, 9, 1237-1245 2007/09 Refereed Disclose to all
Momose K, Makishima H, Ito T, Nakazawa H, Shimodaira S, Kiyosawa K, Ishida F Momose K, Makishima H, Ito T, Nakazawa H, Shimodaira S, Kiyosawa K, Ishida F Momose K, Makishima H, Ito T, Nakazawa H, Shimodaira S, Kiyosawa K, Ishida F Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG. Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG. Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG. International journal of hematology, 86, 2, 174-179 International journal of hematology, 86, 2, 174-179 International journal of hematology, 86, 2, 174-179 2007/08 Refereed Disclose to all
Matsuda K, Hidaka E, Ishida F, Yamauchi K, Makishima H, Ito T, Suzuki T, Imagawa E, Sano K, Katsuyama T, Ota H Matsuda K, Hidaka E, Ishida F, Yamauchi K, Makishima H, Ito T, Suzuki T, Imagawa E, Sano K, Katsuyama T, Ota H Matsuda K, Hidaka E, Ishida F, Yamauchi K, Makishima H, Ito T, Suzuki T, Imagawa E, Sano K, Katsuyama T, Ota H A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5' MLL into 10p12, with concurrent 3' MLL deletion. A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5' MLL into 10p12, with concurrent 3' MLL deletion. A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5' MLL into 10p12, with concurrent 3' MLL deletion. Cancer genetics and cytogenetics, 171, 1, 24-30 Cancer genetics and cytogenetics, 171, 1, 24-30 Cancer genetics and cytogenetics, 171, 1, 24-30 2006/11 Refereed Disclose to all
Makishima H, Ito T, Kodama R, Asano N, Nakazawa H, Hirabayashi K, Nakamura S, Ota M, Akamatsu T, Kiyosawa K, Ishida F Makishima H, Ito T, Kodama R, Asano N, Nakazawa H, Hirabayashi K, Nakamura S, Ota M, Akamatsu T, Kiyosawa K, Ishida F Makishima H, Ito T, Kodama R, Asano N, Nakazawa H, Hirabayashi K, Nakamura S, Ota M, Akamatsu T, Kiyosawa K, Ishida F Intestinal diffuse large B-cell lymphoma associated with celiac disease: a Japanese case. Intestinal diffuse large B-cell lymphoma associated with celiac disease: a Japanese case. Intestinal diffuse large B-cell lymphoma associated with celiac disease: a Japanese case. International journal of hematology, 83, 1, 63-65 International journal of hematology, 83, 1, 63-65 International journal of hematology, 83, 1, 63-65 2006/01 Refereed Disclose to all
Nakazawa H, Ito T, Makishima H, Misawa N, Okiyama W, Uehara T, Hidaka E, Kiyosawa K, Ishida F Nakazawa H, Ito T, Makishima H, Misawa N, Okiyama W, Uehara T, Hidaka E, Kiyosawa K, Ishida F Nakazawa H, Ito T, Makishima H, Misawa N, Okiyama W, Uehara T, Hidaka E, Kiyosawa K, Ishida F Adenovirus fulminant hepatic failure: disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Adenovirus fulminant hepatic failure: disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Adenovirus fulminant hepatic failure: disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Internal medicine (Tokyo, Japan), 45, 16, 975-980 Internal medicine (Tokyo, Japan), 45, 16, 975-980 Internal medicine (Tokyo, Japan), 45, 16, 975-980 2006 Refereed Disclose to all
Choi YL, Moriuchi R, Osawa M, Iwama A, Makishima H, Wada T, Kisanuki H, Kaneda R, Ota J, Koinuma K, Ishikawa M, Takada S, Yamashita Y, Oshimi K, Mano H Choi YL, Moriuchi R, Osawa M, Iwama A, Makishima H, Wada T, Kisanuki H, Kaneda R, Ota J, Koinuma K, Ishikawa M, Takada S, Yamashita Y, Oshimi K, Mano H Choi YL, Moriuchi R, Osawa M, Iwama A, Makishima H, Wada T, Kisanuki H, Kaneda R, Ota J, Koinuma K, Ishikawa M, Takada S, Yamashita Y, Oshimi K, Mano H Retroviral expression screening of oncogenes in natural killer cell leukemia. Retroviral expression screening of oncogenes in natural killer cell leukemia. Retroviral expression screening of oncogenes in natural killer cell leukemia. Leukemia research, 29, 8, 943-949 Leukemia research, 29, 8, 943-949 Leukemia research, 29, 8, 943-949 2005/08 Refereed Disclose to all
Makishima H, Ito T, Asano N, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Suzuki T, Kobayashi H, Kiyosawa K, Ishida F Makishima H, Ito T, Asano N, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Suzuki T, Kobayashi H, Kiyosawa K, Ishida F Makishima H, Ito T, Asano N, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Suzuki T, Kobayashi H, Kiyosawa K, Ishida F Significance of chemokine receptor expression in aggressive NK cell leukemia. Significance of chemokine receptor expression in aggressive NK cell leukemia. Significance of chemokine receptor expression in aggressive NK cell leukemia. Leukemia, 19, 7, 1169-1174 Leukemia, 19, 7, 1169-1174 Leukemia, 19, 7, 1169-1174 2005/07 Refereed Disclose to all
Choi YL, Makishima H, Ohashi J, Yamashita Y, Ohki R, Koinuma K, Ota J, Isobe Y, Ishida F, Oshimi K, Mano H Choi YL, Makishima H, Ohashi J, Yamashita Y, Ohki R, Koinuma K, Ota J, Isobe Y, Ishida F, Oshimi K, Mano H Choi YL, Makishima H, Ohashi J, Yamashita Y, Ohki R, Koinuma K, Ota J, Isobe Y, Ishida F, Oshimi K, Mano H DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions. Leukemia, 18, 3, 556-565 Leukemia, 18, 3, 556-565 Leukemia, 18, 3, 556-565 2004/03 Refereed Disclose to all
Tanaka N, Hora K, Makishima H, Kamijo Y, Kiyosawa K, Gonzalez FJ, Aoyama T Tanaka N, Hora K, Makishima H, Kamijo Y, Kiyosawa K, Gonzalez FJ, Aoyama T Tanaka N, Hora K, Makishima H, Kamijo Y, Kiyosawa K, Gonzalez FJ, Aoyama T In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha. In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha. In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha. FEBS letters, 543, 1-3, 120-124 FEBS letters, 543, 1-3, 120-124 FEBS letters, 543, 1-3, 120-124 2003/05 Refereed Disclose to all
Makishima H, Ishida F, Saito H, Ichikawa N, Ozaki Y, Ito S, Ota M, Katsuyama Y, Kiyosawa K Makishima H, Ishida F, Saito H, Ichikawa N, Ozaki Y, Ito S, Ota M, Katsuyama Y, Kiyosawa K Makishima H, Ishida F, Saito H, Ichikawa N, Ozaki Y, Ito S, Ota M, Katsuyama Y, Kiyosawa K Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes. Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes. Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes. European journal of haematology, 70, 4, 212-218 European journal of haematology, 70, 4, 212-218 European journal of haematology, 70, 4, 212-218 2003/04 Refereed Disclose to all
Makishima H, Ishida F, Ito T, Kitano K, Ueno S, Ohmine K, Yamashita Y, Ota J, Ota M, Yamauchi K, Mano H Makishima H, Ishida F, Ito T, Kitano K, Ueno S, Ohmine K, Yamashita Y, Ota J, Ota M, Yamauchi K, Mano H Makishima H, Ishida F, Ito T, Kitano K, Ueno S, Ohmine K, Yamashita Y, Ota J, Ota M, Yamauchi K, Mano H DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes. DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes. DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes. British journal of haematology, 118, 2, 462-469 British journal of haematology, 118, 2, 462-469 British journal of haematology, 118, 2, 462-469 2002/08 Refereed Disclose to all
Ishida F, Ueno M, Tanaka H, Makishima H, Suzawa K, Hosaka S, Hidaka E, Ishikawa M, Yamauchi K, Kitano K, Kiyosawa K Ishida F, Ueno M, Tanaka H, Makishima H, Suzawa K, Hosaka S, Hidaka E, Ishikawa M, Yamauchi K, Kitano K, Kiyosawa K Ishida F, Ueno M, Tanaka H, Makishima H, Suzawa K, Hosaka S, Hidaka E, Ishikawa M, Yamauchi K, Kitano K, Kiyosawa K t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia. t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia. t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia. Cancer genetics and cytogenetics, 132, 2, 133-135 Cancer genetics and cytogenetics, 132, 2, 133-135 Cancer genetics and cytogenetics, 132, 2, 133-135 2002/01 Refereed Disclose to all
Makishima H, Isobe M, Imamura H Makishima H, Isobe M, Imamura H Makishima H, Isobe M, Imamura H A case of primary cardiac lymphoma: utility of serum soluble interleukin-2 receptor for noninvasive diagnosis. A case of primary cardiac lymphoma: utility of serum soluble interleukin-2 receptor for noninvasive diagnosis. A case of primary cardiac lymphoma: utility of serum soluble interleukin-2 receptor for noninvasive diagnosis. International journal of cardiology, 65, 3, 291-293 International journal of cardiology, 65, 3, 291-293 International journal of cardiology, 65, 3, 291-293 1998/08 Refereed Disclose to all

  • <<
  • >>
Title language:
Patents
Inventor(s) Inventor(s) (Japanese) Inventor(s) (English) Title Title(Japanese) Title(English) Stage Patent number Date Disclose
小川 誠司, 牧島 秀樹, 吉田 健一 小川 誠司, 牧島 秀樹, 吉田 健一 ヒトにおける骨髄腫瘍の発症又は発症リスクを検査する指標の取得方法、ヒトにおけるDDX41遺伝子の体細胞変異の存在又は将来的な発生を予測する指標の取得方法、並びに、これらの検査又は予測のためのキット ヒトにおける骨髄腫瘍の発症又は発症リスクを検査する指標の取得方法、ヒトにおけるDDX41遺伝子の体細胞変異の存在又は将来的な発生を予測する指標の取得方法、並びに、これらの検査又は予測のためのキット 特許公開 特開2017-104035 2017/06/15 Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
研究活動スタート支援 Representative 骨髄系腫瘍における網羅的エクソーム・ゲノム解析 (平成27年度分) 2015/04/01-2016/03/31
基盤研究(B) Representative 骨髄不全症候群における、網羅的シーケンス解析による分子病態の解明 (平成28年度分) 2016/04/01-2017/03/31
基盤研究(B) Representative 骨髄不全症候群における、網羅的シーケンス解析による分子病態の解明 (平成29年度分) 2017/04/01-2018/03/31
基盤研究(B) Representative 骨髄不全症候群における、網羅的シーケンス解析による分子病態の解明 (平成30年度分) 2018/04/01-2019/03/31
Faculty management (title, position)
Title Period
医学図書館図書連絡委員会 2015/04/01-2019/03/31